These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2934800)

  • 21. The effect of fumaric acid esters and dithranol on acanthosis and hyperproliferation in psoriasis vulgaris.
    Bacharaçh-Buhles M; Röchling A; el Gammal S; Altmeyer P
    Acta Derm Venereol; 1996 May; 76(3):190-3. PubMed ID: 8800297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An immunohistochemical assessment of the response of the psoriatic lesion to single and repeated applications of high-dose dithranol cream.
    Swinkels OQ; Prins M; Gerritsen MJ; van Vlijmen-Willems IM; van der Valk PG; van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 2002; 15(6):393-400. PubMed ID: 12476013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes.
    Holstein J; Fehrenbacher B; Brück J; Müller-Hermelink E; Schäfer I; Carevic M; Schittek B; Schaller M; Ghoreschi K; Eberle FC
    J Dermatol Sci; 2017 Sep; 87(3):236-245. PubMed ID: 28673488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adherence of human helper/memory T-cell subsets to psoriatic dermal endothelium.
    Chin YH; Falanga V; Taylor JR; Cai JP; Bax J
    J Invest Dermatol; 1990 Apr; 94(4):413-7. PubMed ID: 1968932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of cyclosporin A on T lymphocyte and dendritic cell sub-populations in psoriasis.
    Baker BS; Griffiths CE; Lambert S; Powles AV; Leonard JN; Valdimarsson H; Fry L
    Br J Dermatol; 1987 Apr; 116(4):503-10. PubMed ID: 3495286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidermal cytokeratin and immunocyte responses during treatment of psoriasis with calcipotriol and betamethasone valerate.
    Berth-Jones J; Fletcher A; Hutchinson PE
    Br J Dermatol; 1992 Apr; 126(4):356-61. PubMed ID: 1373949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of treatment of the paralesional skin with dithranol on healing in psoriasis.
    Stankler L; Dave VK
    Br J Dermatol; 1975 Jan; 92(1):57-61. PubMed ID: 1098687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
    Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
    J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-cell subpopulations in the blood and skin of patients with psoriasis.
    Baker BS; Swain AF; Valdimarsson H; Fry L
    Br J Dermatol; 1984 Jan; 110(1):37-44. PubMed ID: 6229268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electron microscopy of the effects of dithranol on healthy and on psoriatic skin.
    Kanerva L
    Am J Dermatopathol; 1990 Feb; 12(1):51-62. PubMed ID: 2316816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dithranol treatment of plaque-type psoriasis increases serum TNF-like weak inducer of apoptosis (TWEAK).
    Myśliwiec H; Myśliwiec P; Baran A; Flisiak I
    Adv Med Sci; 2016 Sep; 61(2):207-211. PubMed ID: 26895458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of epidermal dendritic cell markers and T-lymphocytes in psoriasis.
    Jones JL; Berth-Jones J; Fletcher A; Hutchinson PE
    J Pathol; 1994 Oct; 174(2):77-82. PubMed ID: 7525911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis: a clinical and pathologic study.
    Gottlieb SL; Heftler NS; Gilleaudeau P; Johnson R; Vallat VP; Wolfe J; Gottlieb AB; Krueger JG
    J Am Acad Dermatol; 1995 Oct; 33(4):637-45. PubMed ID: 7545705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-CD11a ameliorates disease in the human psoriatic skin-SCID mouse transplant model: comparison of antibody to CD11a with Cyclosporin A and clobetasol propionate.
    Zeigler M; Chi Y; Tumas DB; Bodary S; Tang H; Varani J
    Lab Invest; 2001 Sep; 81(9):1253-61. PubMed ID: 11555673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Mahonia aquifolium ointment on the expression of adhesion, proliferation, and activation markers in the skin of patients with psoriasis.
    Augustin M; Andrees U; Grimme H; Schöpf E; Simon J
    Forsch Komplementarmed; 1999 Apr; 6 Suppl 2():19-21. PubMed ID: 10352377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration.
    Haftek M; Faure M; Schmitt D; Thivolet J
    J Invest Dermatol; 1983 Jul; 81(1):10-4. PubMed ID: 6345681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal differentiation characteristics of the psoriatic plaque during short contact treatment with dithranol cream.
    van der Vleuten CJ; de Jong EM; van de Kerkhof PC
    Clin Exp Dermatol; 1996 Nov; 21(6):409-14. PubMed ID: 9167334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-lymphocyte-activating properties of epidermal antigen-presenting cells from normal and psoriatic skin: evidence that psoriatic epidermal antigen-presenting cells resemble cultured normal Langerhans cells.
    Demidem A; Taylor JR; Grammer SF; Streilein JW
    J Invest Dermatol; 1991 Sep; 97(3):454-60. PubMed ID: 1875046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen-presenting cells.
    Baadsgaard O; Gupta AK; Taylor RS; Ellis CN; Voorhees JJ; Cooper KD
    J Invest Dermatol; 1989 Feb; 92(2):190-5. PubMed ID: 2645367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An investigation of the ability of antipsoriatic drugs to inhibit calmodulin activity: a possible mode of action of dithranol (anthralin).
    Tucker WF; MacNeil S; Dawson RA; Tomlinson S; Bleehen SS
    J Invest Dermatol; 1986 Aug; 87(2):232-5. PubMed ID: 3016102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.